Jakarta (ANTARA News) - Publicly traded pharmaceutical company PT Kalbe Farma Tbk (KLBF) reported a 19.6 percent increase in unaudited net profit on-year to Rp807 billion in the first six months of the year.

Vidjongtius, the finance director of the country`s largest pharmaceutical company, attributed the increase in profit to strong growth in sales .

In addition to growing sales, increase in the prices of some products also contributed to the improved financial performance of the company, Vidjongtius said here on Tuesday.

Its financial report showed that its net sales were valued at Rp6.24 trillion or an increase of 26.2 percent.

Its gross profit climbed 18.7 percent with ratio of gross profit to net sales down from 52.1 percent to 49.1 percent.

The net profit per share rose 19.6 percent to Rp86.
(Uu.AS/H-ASG/A014)

Editor: Priyambodo RH
Copyright © ANTARA 2012